Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$106.71 - $143.18 $23,476 - $31,499
-220 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$80.99 - $107.93 $6,965 - $9,281
86 Added 64.18%
220 $94,000
Q1 2021

May 04, 2021

BUY
$84.79 - $104.74 $11,361 - $14,035
134 New
134 $48,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Gvo Asset Management LTD Portfolio

Follow Gvo Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gvo Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gvo Asset Management LTD with notifications on news.